ICU sedation
Conditions
Interventions
experimental group 1:The initial dose of Remimazolam besylate was 5mg, and the additional dose was 2.5mg/ time
experimental group 2:The initial dose of propofol was 1.5mg/kg, and the additional dose was 0.5mg/kg/ time
Sponsors
The Third Affiliated Hospital, Sun Yat-sen University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who intend to undergo fiberoptic bronchoscopy; 2. ASA I-III level; 3. Voluntary participation and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with sedation/anaesthesia contraindications or have a history of abnormal surgical anesthesia recovery; 2. Allergic to local anaesthetics,propofol, benzodiazepines , opioids and their antagonist; 3. Patients with severe heart, brain, lung, liver, kidney and metabolic diseases; 4. Subjects deemed unsuitable to participate in this research by the researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Moderate sedation and success rate were achieved ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to return to pre-test levels of consciousness;Number of cases in which remedial drugs were administered;Degree of satisfaction investigation;Dose explore; | — |
Countries
China
Contacts
Public ContactAn Yuling
Department of Critical Care Medicine, the Third Affiliated Hospital, Sun Yat-sen University
Outcome results
None listed